相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients
F. Girodon et al.
LEUKEMIA (2010)
Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy
Francesca Palandri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia
F. Passamonti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
Federico Lussana et al.
THROMBOSIS RESEARCH (2009)
Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients
Francesco Passamonti et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Leukocytosis and risk stratification assessment in essential thrombocythemia
Alessandra Carobbio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
A. Tefferi et al.
LEUKEMIA (2008)
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
Alessandro M. Vannucchi et al.
BLOOD (2007)
Thrombosis in myeloproliferative disorders: Prevalence, prognostic factors, and the role of leukocytes and JAK2V617F
Akyalew Tefferi et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
The interaction between leukocytosis and other risk factors for thrombosis in essential thrombocythemia
Ayalew Tefferi et al.
BLOOD (2007)
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
Alessandra Carobbio et al.
BLOOD (2007)
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients
N. Gangat et al.
LEUKEMIA (2007)
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders
H Quentmeier et al.
LEUKEMIA (2006)
Essential thrombocythemia beyond the first decade: Life expectancy, long-term complication rates, and prognostic factors
AP Wolanskyj et al.
MAYO CLINIC PROCEEDINGS (2006)
Essential thrombocythaemia: challenges and evidence-based management
CN Harrison
BRITISH JOURNAL OF HAEMATOLOGY (2005)
The World Health Organization (WHO) classification of the myeloid neoplasms
JW Vardiman et al.
BLOOD (2002)